Europe Vegan Climate Index®

Beyond Investing - Investing for Humanity
  • The Europe Vegan Climate Index (VEGANE), developed by Beyond Investing is a passive, rules-based index of European large and mid cap stocks, screened according to vegan and climate-conscious principles.
  • VEGANE excludes companies engaged in animal exploitation, defense, human rights abuses, fossil fuels extraction and energy production, and other environmentally damaging activities.
  • VEGANE demonstrates that it is possible to obtain broad-based market exposure, whilst adhering to animal and environmentally-friendly principles.

Ticker: .VEGANE
Inception date: 3 June 2021

Benchmark: SEULMC Index
Calculation agent: Solactive AG

Number of stocks

Weighted average market cap

Beta

Tracking error

Excess return

164

€26.9bn

1.11

0.31%

-1.06%

Number of stocks

164

Weighted average market cap

€26.9bn

Beta

1.11

Tracking error

0.31%

Excess return

-1.06%

(annualised through 30 June 2024)

Live Index Price Performance

VEGANE Performance

(from 3 June 2021 to 30 June 2024)

Sector Comparison

SEULMCEN
VEGANE

Top 10 Constituents

  • ASML Holding NV – 5.15%
  • SAP SE – 3.77%
  • Schneider Electric SE – 2.86%
  • Allianz SE – 2.65%
  • ABB Ltd – 2.52%
  • RELX PLC – 2.48%
  • Deutsche Telekom AG – 2.42%
  • Zurich Insurance Group Ltd – 2.35%
  • Munich Reinsurance Company – 2.19%
  • NXP Semiconductors NV – 2.17%

(as at 30 June 2024)

Breakdown Of Exclusions

Animal testing - 24%
Animal-derived products - 17%
Financing of exclusions - 9%
Fossil fuel - 8%
Military and defence - 5%
Other environmental and human rights - 4%
Energy production from fossil fuel - 2%
Animals in sport and entertainment - 1%

(as at 30 June 2024)

Impact Metrics

Vegane - Impact Metrics

Animal Impact

12,000 animals “spared” per $1 million of VEGANE invested in for one year.

The above figure is based on: land animals killed (17 billion), fish caught and farmed (298 billion), egg-laying hens (1.5 billion), dairy cows (60 million) and animals used for testing (26 million).
Europe proportion of global annual figures from National Center for Biotechnology Information, GreenFacts, FAOstat

Beyond Investing - Bamboo